ArticleAsian Pacific journal of cancer prevention : APJCP2025
Effect of Curcuma Longa Extract to Granzyme Expression and Tumor Mass Diameter of Mammary Adenocarcinoma with Chemotherapy Adriamycin Cyclophosphamide: An Animal Study in Rats.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to prove the effectiveness of the curcuma longa extract to mammary adenocarcinoma with chemotherapy.
methodsThis research employs an in vivo experimental laboratory design with a post-test-only control group. Thirty female Balb/c mice with mammary adenocarcinoma were randomly assigned to five groups: K- (without chemotherapy), K+ (with chemotherapy), P1 (chemotherapy with 100 mg C. longa), P2 (chemotherapy with 150 mg C. longa), and P3 (chemotherapy with 200 mg C. longa). After a five-week treatment period, granzyme expression was examined by immunohistochemistry, and tumor diameter was measured. Data normality test using the Shapiro-Wilk test, then homogeneity test using the Levene test. Tumor diameter use test with One Way Anova followed by the Post Hoc LSD test to determine differences between groups. Statistical significance was defined as p <0.05.
resultThe highest levels of granzyme expression were observed in the P3 group, with the results P3 were 51.83±19.66 and data was found to be normally homogeneous (p: 0,137) and distributed (p: 0,486). A comparative analysis revealed notable disparities between K-vsP3 (p=0.001), K+vsP1 (p=0.028), K+vsP2 (p=0.016), K+vsP3 (p=<0.001), and P1vsP3 (p=0.037). The smallest tumor diameter was observed in the P3 group, with the results for group P3 were 10.55±2.33 and and data was found to be normally homogeneous (p: 0,667) and distributed (p: 0,796).
conclusionThe administration of Curcuma longa extract in conjunction with chemotherapy has been demonstrated to enhance granzyme expression and reduce tumor diameter in mammary adenocarcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.